Tag: CHOP


  • ER Stress Biomarkers in COPD: Key Indicators for Management

    ER Stress Biomarkers in COPD: Key Indicators for Management

    Introduction Chronic obstructive pulmonary disease (COPD) encompasses a spectrum of chronic inflammatory lung diseases characterized by persistent airflow limitation and progressive decline in lung function. Beyond traditional risk factors like tobacco exposure, accumulating evidence highlights the role of cellular stress responses—particularly endoplasmic reticulum (ER) stress—in COPD pathogenesis. ER stress activates the unfolded protein response (UPR),…

  • ER Stress-Related Biomarkers in COPD: Unlocking New Insights for Diagnosis and Therapy

    ER Stress-Related Biomarkers in COPD: Unlocking New Insights for Diagnosis and Therapy

    Understanding ER Stress and COPD Chronic obstructive pulmonary disease (COPD) is a complex, heterogeneous condition marked by persistent inflammation and progressive decline in lung function. Recent research highlights the role of endoplasmic reticulum (ER) stress as a key cellular stress response in COPD. When misfolded proteins accumulate in the ER, a signaling cascade known as…

  • ER Stress Biomarkers in COPD: Key Indicators of Disease Activity

    ER Stress Biomarkers in COPD: Key Indicators of Disease Activity

    Introduction to ER Stress and COPD Chronic obstructive pulmonary disease (COPD) is a heterogeneous respiratory condition marked by persistent inflammation, airway remodeling, and progressive loss of lung function. In recent years, researchers have turned to cellular stress pathways to better understand COPD pathogenesis. A central player is endoplasmic reticulum (ER) stress, a cellular state triggered…

  • New Study Links Placental Malperfusion to Fetal Health in Congenital Heart Disease

    New Study Links Placental Malperfusion to Fetal Health in Congenital Heart Disease

    Overview: Placental Malperfusion and Congenital Heart Disease Researchers at the Children’s Hospital of Philadelphia (CHOP) have unveiled findings that connect placental malperfusion with fetal health and development in pregnancies affected by congenital heart disease (CHD). The study underscores how disruptions in placental blood flow, along with genetic and developmental pathways, can influence fetal growth, organ…

  • Placental Malperfusion and Congenital Heart Disease: How Fetal Development Hinges on Placental Health

    Placental Malperfusion and Congenital Heart Disease: How Fetal Development Hinges on Placental Health

    New Insights into Placental Malperfusion and Fetal Outcomes in Congenital Heart Disease Researchers at the Children’s Hospital of Philadelphia (CHOP) have unveiled evidence that placental malperfusion—insufficient or uneven blood flow through the placenta—can significantly influence fetal health and development in fetuses affected by congenital heart disease (CHD). The study emphasizes how genetic and developmental pathways…